• Post category:Blog
  • Post comments:0 Comments
  • Reading time:8 mins read

GLAMOR-P (Glimepiride IP 2 mg + Pioglitazone Hydrochloride 15 mg Tablets): Uses, MOA, Benefits, and Recommended Dosage

Glimepiride IP 2 mg Pioglitazone Hydrochloride 15 mg Tablet

Introduction:

GLAMOR-P, crafted by Invision Medi Sciences, combines the potent duo of Glimepiride IP 2 mg and Pioglitazone Hydrochloride 15 mg to tackle the complexities of type 2 diabetes. This guide delves into the therapeutic synergy of these two ingredients, emphasizing the significance of their combined efficacy in diabetes management.

The Power of Glimepiride and Pioglitazone:

GLAMOR-P harnesses the glucose-lowering prowess of Glimepiride and the insulin-sensitizing effects of Pioglitazone, offering a comprehensive approach to glycemic control. Discover how these ingredients work synergistically to address insulin resistance and regulate blood sugar levels.

Indications for GLAMOR-P:

  1. Type 2 Diabetes Mellitus: GLAMOR-P is indicated for individuals with type 2 diabetes who require pharmacological intervention to achieve glycemic control.
  2. Dual Therapy: It serves as an adjunct to diet and exercise in patients inadequately controlled on monotherapy or those requiring dual therapy.

Benefits of GLAMOR-P:

  1. Glucose Regulation: Glimepiride stimulates insulin secretion, while Pioglitazone improves insulin sensitivity and reduces hepatic glucose production, collectively aiding in glucose regulation.
  2. Cardiometabolic Benefits: Pioglitazone’s additional benefits include improvements in lipid profiles and reductions in cardiovascular risk factors, offering broader cardiometabolic benefits beyond glycemic control.

Recommended Dosage:

The recommended dosage of GLAMOR-P is determined based on individual patient factors and glycemic control. Healthcare providers typically initiate therapy with one tablet daily, titrating the dose as necessary to achieve optimal glycemic outcomes.

Potential Side Effects:

While generally well-tolerated, GLAMOR-P may cause side effects such as:

  • Hypoglycemia: Glimepiride’s insulin secretagogue effect may lead to hypoglycemia, especially in susceptible individuals.
  • Gastrointestinal Disturbances: Metformin may cause gastrointestinal symptoms such as nausea, vomiting, or diarrhea.

Essential Information:

  1. Regular Monitoring: Regular monitoring of blood glucose levels, liver function tests, and signs of heart failure is recommended during GLAMOR-P therapy.
  2. Patient Counseling: Patients should be counseled regarding the potential risks and benefits of GLAMOR-P, including the importance of adhering to dietary and lifestyle modifications.

Conclusion:

GLAMOR-P exemplifies Invision Medi Sciences’ commitment to providing comprehensive solutions for diabetes management. By combining Glimepiride and Pioglitazone, GLAMOR-P offers a multifaceted approach to glycemic control and cardiometabolic health.

Related Combinations:

Explore our range of diabetes management solutions at Invision Medi Sciences.

GLAMOR-P: Empowering individuals with the combined efficacy of Glimepiride and Pioglitazone for effective diabetes control.

FAQs


How does GLAMOR-P help in managing type 2 diabetes?

GLAMOR-P combines Glimepiride and Pioglitazone to regulate blood sugar levels by stimulating insulin secretion and improving insulin sensitivity, respectively.

What is the recommended dosage regimen for GLAMOR-P?

Healthcare providers typically initiate GLAMOR-P therapy with one tablet daily, adjusting the dose based on individual glycemic response and tolerability.

Can GLAMOR-P cause hypoglycemia?

Yes, GLAMOR-P may lead to hypoglycemia, especially if the dose is not adjusted appropriately. Patients should be educated on recognizing and managing low blood sugar levels.

Are there any specific monitoring requirements while taking GLAMOR-P?

Regular monitoring of blood glucose levels, liver function tests, and signs of heart failure is recommended during GLAMOR-P therapy to ensure safety and efficacy.

Is GLAMOR-P suitable for all individuals with type 2 diabetes?

GLAMOR-P is indicated for individuals with type 2 diabetes who require pharmacological intervention to achieve glycemic control. However, its suitability may vary based on individual patient factors and medical history.

Leave a Reply


The reCAPTCHA verification period has expired. Please reload the page.